Accuracy of Cough Detection in Healthy Adults

This study has been completed.
Sponsor:
Information provided by:
KarmelSonix Ltd.
ClinicalTrials.gov Identifier:
NCT00907491
First received: May 21, 2009
Last updated: June 8, 2011
Last verified: May 2009
  Purpose

Cough is part of the defense mechanism to protect the lung from foreign particles and remove secretions from the airways. However, at times it becomes a bothersome, annoying symptom that interferes with the quality of life, sleep pattern and exercise tolerance of the patient.

People with respiratory infection, asthmatic patients and CF patients suffer from a multitude of pathologies of airways and are often inflicted with chronic cough.

Treatment of cough in these patients consists of many types of expectorants, cough suppressors, secretion modifiers, inhaled bronchodilators etc. In addition, chest physical therapy (PT) is often prescribed as part of the treatment regime.

The primary objective of the study is to evaluate the efficacy and validity of novel cough counting device based on the WIM Technology.


Condition Intervention
Cough
Device: pulmonary sounds analyzer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Use of Objective Cough Counting Device to Assess the Accuracy of Cough Detection in Healthy Adults Simulating Cough in Different Postures, Mobility and Environmental Conditions

Resource links provided by NLM:


Further study details as provided by KarmelSonix Ltd.:

Primary Outcome Measures:
  • To evaluate cough detection and counting technology (ACCA) for adult people in different recording conditions [ Time Frame: within 2 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 54
Study Start Date: February 2008
Study Completion Date: July 2009
Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
A Device: pulmonary sounds analyzer
Cough counting device based on the WIM Technology

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy adults 21 years and above

Criteria

Inclusion Criteria:

  • Patient signed informed consent
  • Patients above 21 years old
  • No medical history

Exclusion Criteria:

  • Skin lesions precluding attachment of sensors
  • Pregnancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00907491

Locations
Israel
RAMBAM Health Care Campus
Haifa,, Israel, 31096
Sponsors and Collaborators
KarmelSonix Ltd.
  More Information

No publications provided

Responsible Party: Dr. Hanna Levy - Director of clinical studies, KarmelSonix Ltd
ClinicalTrials.gov Identifier: NCT00907491     History of Changes
Other Study ID Numbers: WIM-CC 01
Study First Received: May 21, 2009
Last Updated: June 8, 2011
Health Authority: Israel: Ethics Commission

Keywords provided by KarmelSonix Ltd.:
Cough
Wheeze Rate
Respiratory Function Tests

Additional relevant MeSH terms:
Cough
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms

ClinicalTrials.gov processed this record on April 15, 2014